BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

436 related articles for article (PubMed ID: 17689286)

  • 1. Tumour cell proliferation under hypoxic conditions in human head and neck squamous cell carcinomas.
    Wijffels KI; Marres HA; Peters JP; Rijken PF; van der Kogel AJ; Kaanders JH
    Oral Oncol; 2008 Apr; 44(4):335-44. PubMed ID: 17689286
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Erythropoietin receptor is not a surrogate marker for tumor hypoxia and does not correlate with survival in head and neck squamous cell carcinomas.
    Hoogsteen IJ; Peeters WJ; Marres HA; Rijken PF; van den Hoogen FJ; van der Kogel AJ; Kaanders JH
    Radiother Oncol; 2005 Aug; 76(2):213-8. PubMed ID: 16112214
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin-12 has no effect on vascular density, perfusion, hypoxia and proliferation of an implanted human squamous cell carcinoma xenograft tumour despite up-regulation of ICAM-1.
    van Herpen CM; Bussink J; van der Kogel AJ; Peeters WJ; van der Voort R; van Schijndel A; de Wilde PC; Adema GJ; de Mulder PH
    Anticancer Res; 2005; 25(2A):1015-21. PubMed ID: 15868941
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The fate of hypoxic (pimonidazole-labelled) cells in human cervix tumours undergoing chemo-radiotherapy.
    Durand RE; Aquino-Parsons C
    Radiother Oncol; 2006 Aug; 80(2):138-42. PubMed ID: 16916562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of EGFR under tumor hypoxia: identification of a subpopulation of tumor cells responsible for aggressiveness and treatment resistance.
    Hoogsteen IJ; Marres HA; van den Hoogen FJ; Rijken PF; Lok J; Bussink J; Kaanders JH
    Int J Radiat Oncol Biol Phys; 2012 Nov; 84(3):807-14. PubMed ID: 22420963
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Colocalization of carbonic anhydrase 9 expression and cell proliferation in human head and neck squamous cell carcinoma.
    Hoogsteen IJ; Marres HA; Wijffels KI; Rijken PF; Peters JP; van den Hoogen FJ; Oosterwijk E; van der Kogel AJ; Kaanders JH
    Clin Cancer Res; 2005 Jan; 11(1):97-106. PubMed ID: 15671533
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does heterogeneity of pimonidazole labelling correspond to the heterogeneity of radiation-response of FaDu human squamous cell carcinoma?
    Yaromina A; Hölscher T; Eicheler W; Rosner A; Krause M; Hessel F; Petersen C; Thames HD; Baumann M; Zips D
    Radiother Oncol; 2005 Aug; 76(2):206-12. PubMed ID: 16024121
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIF-1A, pimonidazole, and iododeoxyuridine to estimate hypoxia and perfusion in human head-and-neck tumors.
    Janssen HL; Haustermans KM; Sprong D; Blommestijn G; Hofland I; Hoebers FJ; Blijweert E; Raleigh JA; Semenza GL; Varia MA; Balm AJ; van Velthuysen ML; Delaere P; Sciot R; Begg AC
    Int J Radiat Oncol Biol Phys; 2002 Dec; 54(5):1537-49. PubMed ID: 12459383
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A clinical study of hypoxia and metallothionein protein expression in squamous cell carcinomas.
    Raleigh JA; Chou SC; Calkins-Adams DP; Ballenger CA; Novotny DB; Varia MA
    Clin Cancer Res; 2000 Mar; 6(3):855-62. PubMed ID: 10741707
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The prognostic value of pimonidazole and tumour pO2 in human cervix carcinomas after radiation therapy: a prospective international multi-center study.
    Nordsmark M; Loncaster J; Aquino-Parsons C; Chou SC; Gebski V; West C; Lindegaard JC; Havsteen H; Davidson SE; Hunter R; Raleigh JA; Overgaard J
    Radiother Oncol; 2006 Aug; 80(2):123-31. PubMed ID: 16890316
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pimonidazole binding and tumor vascularity predict for treatment outcome in head and neck cancer.
    Kaanders JH; Wijffels KI; Marres HA; Ljungkvist AS; Pop LA; van den Hoogen FJ; de Wilde PC; Bussink J; Raleigh JA; van der Kogel AJ
    Cancer Res; 2002 Dec; 62(23):7066-74. PubMed ID: 12460928
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pimonidazole labelling and response to fractionated irradiation of five human squamous cell carcinoma (hSCC) lines in nude mice: the need for a multivariate approach in biomarker studies.
    Yaromina A; Zips D; Thames HD; Eicheler W; Krause M; Rosner A; Haase M; Petersen C; Raleigh JA; Quennet V; Walenta S; Mueller-Klieser W; Baumann M
    Radiother Oncol; 2006 Nov; 81(2):122-9. PubMed ID: 16956683
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypoxia in relation to vasculature and proliferation in liver metastases in patients with colorectal cancer.
    van Laarhoven HW; Kaanders JH; Lok J; Peeters WJ; Rijken PF; Wiering B; Ruers TJ; Punt CJ; Heerschap A; van der Kogel AJ
    Int J Radiat Oncol Biol Phys; 2006 Feb; 64(2):473-82. PubMed ID: 16242253
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The immunohistochemical assessment of hypoxia, vascularity and proliferation in bladder carcinoma.
    Hoskin PJ; Sibtain A; Daley FM; Saunders MI; Wilson GD
    Radiother Oncol; 2004 Aug; 72(2):159-68. PubMed ID: 15297134
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vascular architecture and hypoxic profiles in human head and neck squamous cell carcinomas.
    Wijffels KI; Kaanders JH; Rijken PF; Bussink J; van den Hoogen FJ; Marres HA; de Wilde PC; Raleigh JA; van der Kogel AJ
    Br J Cancer; 2000 Sep; 83(5):674-83. PubMed ID: 10944611
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison between the comet assay and pimonidazole binding for measuring tumour hypoxia.
    Olive PL; Durand RE; Raleigh JA; Luo C; Aquino-Parsons C
    Br J Cancer; 2000 Dec; 83(11):1525-31. PubMed ID: 11076663
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypoxia in human colorectal adenocarcinoma: comparison between extrinsic and potential intrinsic hypoxia markers.
    Goethals L; Debucquoy A; Perneel C; Geboes K; Ectors N; De Schutter H; Penninckx F; McBride WH; Begg AC; Haustermans KM
    Int J Radiat Oncol Biol Phys; 2006 May; 65(1):246-54. PubMed ID: 16618579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro radiosensitivity of tumour cells and fibroblasts derived from head and neck carcinomas: mutual relationship and correlation with clinical data.
    Stausbøl-Grøn B; Bentzen SM; Jørgensen KE; Nielsen OS; Bundgaard T; Overgaard J
    Br J Cancer; 1999 Mar; 79(7-8):1074-84. PubMed ID: 10098739
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence for lymphangiogenesis and its prognostic implications in head and neck squamous cell carcinoma.
    Kyzas PA; Geleff S; Batistatou A; Agnantis NJ; Stefanou D
    J Pathol; 2005 Jun; 206(2):170-7. PubMed ID: 15846845
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene expression classifier predicts for hypoxic modification of radiotherapy with nimorazole in squamous cell carcinomas of the head and neck.
    Toustrup K; Sørensen BS; Lassen P; Wiuf C; Alsner J; Overgaard J;
    Radiother Oncol; 2012 Jan; 102(1):122-9. PubMed ID: 21996521
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.